Recent publications from members of the Division of Hematology at WashU Med, emphasize the ongoing safety challenges of anticoagulant therapies in high-risk patient populations.
“The first month after direct oral anticoagulants: a window of vulnerability” (published in Research and Practice in Thrombosis and Haemostasis), is commentary from Amber Afzal, MD, MSCI on direct oral anticoagulants (DOACs).
“Anticoagulant Therapy and Bleeding-Related Hospitalizations in Patients With Cancer” (published in American Journal of Hematology), evaluates data from a nationwide U.S. Veterans cohort. Hematology members, Amber Afzal, MD, MSCI, Amir Mahmoud, MBBCh, Kristen M. Sanfilippo, MD, MPHS, and Suhong Luo, MPH, contributed to this article.